It might be a confounding biomarker for advanced CRC stages since cell surface CD26 is a biomarker of some metastatic cancer stem cells (CSC) [19], and serum sCD26 levels were found enhanced in CRC advanced tumor stages [20,21]. This evidence concerns the gene DPP4 and neoplasm.